Klemm G, Putzke H P
Dtsch Z Verdau Stoffwechselkr. 1981;41(3):128-34.
The application of the diphosphonate EHDP (ethane-I-hydroxy-I,I-diphosphonate) prior to the commencement of a calciphylactic experiment (SELYE) inhibits the interstitial calcification and fixation of apatite in the pancreas of female rats (dosage: 20 mgEHDP i. p. per 150 g body mass). Thus the inhibitory potency of EHDP on soft tissue calcification is confirmed. Previously, on the basis of experimental results, a therapeutic administration of this substance in the field of clinical pancreatology could not be derived because the most of human intraductal calculi is composed of calcium carbonate.
在开展钙质沉着实验(赛莱氏实验)之前应用二膦酸盐EHDP(乙烷-1-羟基-1,1-二膦酸盐),可抑制雌性大鼠胰腺中的间质钙化以及磷灰石的固定(剂量:每150克体重腹腔注射20毫克EHDP)。由此证实了EHDP对软组织钙化的抑制效力。此前,基于实验结果,无法得出在临床胰腺病学领域对该物质进行治疗性给药的结论,因为大多数人体导管结石是由碳酸钙构成的。